Erasca, Inc.

NASDAQ: ERAS · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0001761918Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 59DQ —GM —SS 58

v0.1 · 35/100 weight · pillars only

↑ Altman-Z, market scale · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$124.5M

Employees

103

Market cap

$5.7B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$124.5M-$124.5M2025

Operating income-$140.9M-$140.9M2025

Total assets$396.2M$396.2M2025

Liabilities$71.0M$71.0M2025

Equity$325.2M$325.2M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Erasca, Inc. earned -$124.5M in FY2025 net income.

Peers · Healthcare

Belite Bio, Inc——Teleflex Incorporated77B+BillionToOne, Inc.53D Legend Biotech Corporation——

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Sempra$12.4B64C Realty Income Corporation$5.7B59C ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+DexCom, Inc.$4.7B87A

Key facts

CEOJonathan E. Lim

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: ERAS

Employees103

IPO date2021-07-16

Latest filings

8-K2026-07-01 8-K2026-05-11 10-Q2026-05-11 DEF 14A2026-04-28 8-K2026-04-27 8-K2026-04-27 8-K2026-04-21 10-K2026-03-12

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.